Safety reporting and adverse-event profile of mirtazapine described in randomized controlled trials in comparison with other classes of antidepressants in the acute-phase treatment of adults with depression: systematic review and meta-analysis.

Saved in:

Bibliographic Details
Title:	Safety reporting and adverse-event profile of mirtazapine described in randomized controlled trials in comparison with other classes of antidepressants in the acute-phase treatment of adults with depression: systematic review and meta-analysis.
Authors:	Watanabe N (AUTHOR), Omori IM (AUTHOR), Nakagawa A (AUTHOR), Cipriani A (AUTHOR), Barbui C (AUTHOR), McGuire H (AUTHOR), Churchill R (AUTHOR), Furukawa TA (AUTHOR), MANGA (Meta-Analysis of New Generation Antidepressants) Study Group (CORPORATE AUTHOR), Watanabe, Norio¹ (AUTHOR), Omori, Ichiro M (AUTHOR), Nakagawa, Atsuo (AUTHOR), Cipriani, Andrea (AUTHOR), Barbui, Corrado (AUTHOR), McGuire, Hugh (AUTHOR), Churchill, Rachel (AUTHOR), Furukawa, Toshi A (AUTHOR)
Source:	CNS Drugs. 2010, Vol. 24 Issue 1, p35-53.
Database:	SPORTDiscus with Full Text

Description
ISSN:	11727047
DOI:	10.2165/11319480-000000000-00000